Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 20...(2) 355-4449 ext. 127 (212) ...),Health
Navigation Links
Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results
Date:9/15/2008
2) 355-4449 ext. 127 (212) 355-4449 ext. 173
asiegel@joelefrank.com jwert@joelefrank.com
'/>"/>
| SOURCE Optical Cable Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Shamir Optical Industry Ltd. to Host Conference Call Announcing Second Quarter 2008 Earnings Results
2. Transitions Optical Offers Tips on How to Protect Eyes for Outdoor Sports Fans
3. Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH
4. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
5. AUDIO from Medialink and Transitions Optical: What You Cant See May Harm You
6. Shamir Optical Industry Ltd. Reports First Quarter 2008 Results
7. Scientists in Japan design first optical pacemaker for laboratory research
8. Shamir Optical Industry Ltd. to Host Conference Call Announcing First Quarter 2008 Earnings Results
9. Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2007 Results
10. Shamir Optical Industry Ltd. to Host Conference Call Announcing Fourth Quarter and Year End 2007 Earnings Results
11. Optical frequency comb can detect the breath of disease
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Polar Pump: E85 Fuel Now Available in Warroad, Minn., Northernmost Outlet for the Fuel in USA 2Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 2Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 3Health News:Bone Marrow Transplants May Cure Sickle Cell in Adults 2Health News:Bone Marrow Transplants May Cure Sickle Cell in Adults 3Health News:Bone Marrow Transplants May Cure Sickle Cell in Adults 4
[1] Amilpar - Relevant Fact - Public Offer[0] Polar Pump: E85 Fuel Now Available in Warroad, Minn., Northernmost Outlet for the Fuel in USA[0] Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress[0] News brief: Dermatologic infections in cancer patients treated with EGFRI therapy[0] Bone Marrow Transplants May Cure Sickle Cell in Adults
Other Medicine News:Health News:Serum carcinoembryonic antigen level can reflect adrenal adenoma 2Health News:Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 2Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing Third Quarter 2007 Earnings Results 2Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 2Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 3Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 4Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 5Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 6Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 7Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 8Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 9Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 10Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 11Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 12Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 13Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 14Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 15Health News:Major EU Funded Nanotube Research Group, DESYGN-IT, Publish in AZoJono - The Open Access Online Nanotech Journal 2Health News:CHF International Named Global Fund Principal Recipient in Honduras 2
Serum carcinoembryonic antigen level can reflect adrenal adenomaGenomic Health to Present at 19th Annual Piper Jaffray Health Care ConferenceShamir Optical Industry Ltd. to Host Conference Call Announcing Third Quarter 2007 Earnings ResultsPar Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007Major EU Funded Nanotube Research Group, DESYGN-IT, Publish in AZoJono - The Open Access Online Nanotech JournalCHF International Named Global Fund Principal Recipient in Honduras
Breaking Medicine Technology:Helix BioPharma Reports On 2009 Annual General Meeting 2Helix BioPharma Reports On 2009 Annual General Meeting 3The SCOOTER Store Launches New Advertising Highlighting the Value and Cost Savings From Medicare's Power Mobility Benefit 2NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Detecting early signs of osteoarthritis 52570 1Detecting early signs of osteoarthritis 52570 2Short stressful events may improve working memory 9335 1Short stressful events may improve working memory 9335 2EPA grant to University of Chicago for research on food allergy triggers 9332 1
Other Medicine Technology:Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 2Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 3VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 2VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 3VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 4VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 5VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 6VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 7
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |